NMR Solution Structure of the Human Prion Protein

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2000 Jan 5

PMID 10618385

Citations 362

Authors

R Zahn

A Liu

T Luhrs

R Riek

C von Schroetter

F Lopez Garcia

M Billeter

L Calzolai

G Wider

K Wuthrich

Affiliations

Soon will be listed here.

Abstract

The NMR structures of the recombinant human prion protein, hPrP(23-230), and two C-terminal fragments, hPrP(90-230) and hPrP(121-230), include a globular domain extending from residues 125-228, for which a detailed structure was obtained, and an N-terminal flexibly disordered "tail." The globular domain contains three alpha-helices comprising the residues 144-154, 173-194, and 200-228 and a short anti-parallel beta-sheet comprising the residues 128-131 and 161-164. Within the globular domain, three polypeptide segments show increased structural disorder: i.e., a loop of residues 167-171, the residues 187-194 at the end of helix 2, and the residues 219-228 in the C-terminal part of helix 3. The local conformational state of the polypeptide segments 187-193 in helix 2 and 219-226 in helix 3 is measurably influenced by the length of the N-terminal tail, with the helical states being most highly populated in hPrP(23-230). When compared with the previously reported structures of the murine and Syrian hamster prion proteins, the length of helix 3 coincides more closely with that in the Syrian hamster protein whereas the disordered loop 167-171 is shared with murine PrP. These species variations of local structure are in a surface area of the cellular form of PrP that has previously been implicated in intermolecular interactions related both to the species barrier for infectious transmission of prion disease and to immune reactions.

Citing Articles

Structures of Oligomeric States of Tau Protein, Amyloid-β, α-Synuclein and Prion Protein Implicated in Alzheimer's Disease, Parkinson's Disease and Prionopathies.

Cehlar O, Njemoga S, Horvath M, Cizmazia E, Bednarikova Z, Barrera E Int J Mol Sci. 2024; 25(23).

PMID: 39684761 PMC: 11641156. DOI: 10.3390/ijms252313049.

Unfolding Mechanism and Fibril Formation Propensity of Human Prion Protein in the Presence of Molecular Crowding Agents.

Madheswaran M, Ventserova N, DAbrosca G, Salzano G, Celauro L, Cazzaniga F Int J Mol Sci. 2024; 25(18).

PMID: 39337404 PMC: 11432716. DOI: 10.3390/ijms25189916.

Cellular Prion Protein Conformational Shift after Liquid-Liquid Phase Separation Regulated by a Polymeric Antagonist and Mutations.

Liu Y, Tuttle M, Kostylev M, Roseman G, Zilm K, Strittmatter S J Am Chem Soc. 2024; 146(40):27903-27914.

PMID: 39326869 PMC: 11469297. DOI: 10.1021/jacs.4c10590.

Protein Fold Usages in Ribosomes: Another Glance to the Past.

Tanoz I, Timsit Y Int J Mol Sci. 2024; 25(16).

PMID: 39201491 PMC: 11354259. DOI: 10.3390/ijms25168806.

Prion protein E219K polymorphism: from the discovery of the KANNO blood group to interventions for human prion disease.

Wang S, Meng Z, Zhang Y, Yan Y, Li L Front Neurol. 2024; 15:1392984.

PMID: 39050130 PMC: 11266091. DOI: 10.3389/fneur.2024.1392984.

References

Luginbuhl P, Guntert P, Billeter M, Wuthrich K . The new program OPAL for molecular dynamics simulations and energy refinements of biological macromolecules. J Biomol NMR. 1996; 8(2):136-46. DOI: 10.1007/BF00211160. View

Weissmann C . The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies. FEBS Lett. 1996; 389(1):3-11. DOI: 10.1016/0014-5793(96)00610-2. View

Stahl N, Baldwin M, Teplow D, Hood L, Gibson B, Burlingame A . Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 1993; 32(8):1991-2002. DOI: 10.1021/bi00059a016. View

Wuthrich K . NMR - this other method for protein and nucleic acid structure determination. Acta Crystallogr D Biol Crystallogr. 1995; 51(Pt 3):249-70. DOI: 10.1107/S0907444994010188. View

Prusiner S . Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci. 1996; 21(12):482-7. DOI: 10.1016/s0968-0004(96)10063-3. View

Telling G, Scott M, Hsiao K, Foster D, Yang S, Torchia M . Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A. 1994; 91(21):9936-40. PMC: 44932. DOI: 10.1073/pnas.91.21.9936. View

Telling G, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen F . Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell. 1995; 83(1):79-90. DOI: 10.1016/0092-8674(95)90236-8. View

Wishart D, Sykes B . The 13C chemical-shift index: a simple method for the identification of protein secondary structure using 13C chemical-shift data. J Biomol NMR. 1994; 4(2):171-80. DOI: 10.1007/BF00175245. View

Kaneko K, Zulianello L, Scott M, Cooper C, Wallace A, James T . Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc Natl Acad Sci U S A. 1997; 94(19):10069-74. PMC: 23307. DOI: 10.1073/pnas.94.19.10069. View

10.

Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wuthrich K . Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci U S A. 1998; 95(20):11667-72. PMC: 21698. DOI: 10.1073/pnas.95.20.11667. View

11.

Liu H, Farr-Jones S, Ulyanov N, Llinas M, Marqusee S, Groth D . Solution structure of Syrian hamster prion protein rPrP(90-231). Biochemistry. 1999; 38(17):5362-77. DOI: 10.1021/bi982878x. View

12.

Neri D, Szyperski T, Otting G, Senn H, Wuthrich K . Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling. Biochemistry. 1989; 28(19):7510-6. DOI: 10.1021/bi00445a003. View

13.

Schatzl H, Da Costa M, Taylor L, Cohen F, Prusiner S . Prion protein gene variation among primates. J Mol Biol. 1995; 245(4):362-74. DOI: 10.1006/jmbi.1994.0030. View

14.

Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K . NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 1997; 413(2):282-8. DOI: 10.1016/s0014-5793(97)00920-4. View

15.

Alper T, Cramp W, HAIG D, Clarke M . Does the agent of scrapie replicate without nucleic acid?. Nature. 1967; 214(5090):764-6. DOI: 10.1038/214764a0. View

16.

Griffith J . Self-replication and scrapie. Nature. 1967; 215(5105):1043-4. DOI: 10.1038/2151043a0. View

17.

Szyperski T, Luginbuhl P, Otting G, Guntert P, Wuthrich K . Protein dynamics studied by rotating frame 15N spin relaxation times. J Biomol NMR. 1993; 3(2):151-64. DOI: 10.1007/BF00178259. View

18.

Guntert P, Braun W, Wuthrich K . Efficient computation of three-dimensional protein structures in solution from nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. J Mol Biol. 1991; 217(3):517-30. DOI: 10.1016/0022-2836(91)90754-t. View

19.

Guntert P, Mumenthaler C, Wuthrich K . Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol. 1997; 273(1):283-98. DOI: 10.1006/jmbi.1997.1284. View

20.

Zahn R, Buckle A, Perrett S, Johnson C, Corrales F, Golbik R . Chaperone activity and structure of monomeric polypeptide binding domains of GroEL. Proc Natl Acad Sci U S A. 1996; 93(26):15024-9. PMC: 26349. DOI: 10.1073/pnas.93.26.15024. View